The value of 18F-FDG-PET/CT in the diagnosis of solitary pulmonary nodules
Open Access
- 1 March 2018
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Medicine
- Vol. 97 (12), e0130
- https://doi.org/10.1097/md.0000000000010130
Abstract
Solitary pulmonary nodules (SPNs) are common imaging findings. Many studies have indicated that 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) is an accurate test for distinguishing benign and malignant SPNs. The aim of this study was to investigate the value of 18F-FDG-PET/CT in the diagnosis of malignant SPNs. We systematically searched the PubMed and Embase databases up to March 2017, and published data on sensitivity, specificity, and other measures of diagnostic accuracy of 18F-FDG-PET/CT in the diagnosis of malignant SPNs were meta-analyzed. Statistical analyses were undertaken using Meta-DiSc 1.4 software and Stata version 12.0. The measures of accuracy of 18F-FDG-PET/CT in the diagnosis of malignant SPNs were pooled using random-effects models. A total of 20 publications reporting 21 studies were identified. Pooled results indicated that 18F-FDG-PET/CT showed a diagnostic sensitivity of 0.89 (95% confidence interval [CI], 0.87–0.91) and a specificity of 0.70 (95% CI, 0.66–0.73). The positive likelihood ratio was 3.33 (95% CI, 2.35–4.71) and the negative likelihood ratio was 0.18 (95% CI, 0.13–0.25). The diagnostic odds ratio was 22.43 (95% CI, 12.55–40.07). 18F-FDG-PET/CT showed insufficient sensitivity and specificity for diagnosing malignant SPNs; it cannot replace the “gold standard” pathology by resection or percutaneous biopsy. Larger studies are required for further evaluation.Keywords
This publication has 53 references indexed in Scilit:
- Results of the Two Incidence Screenings in the National Lung Screening TrialThe New England Journal of Medicine, 2013
- FDG PET/CT evaluation of pathologically proven pulmonary lesions in an area of high endemic granulomatous diseaseAnnals of Nuclear Medicine, 2013
- Decision Making in Patients with Pulmonary NodulesAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective studyActa Oncologica, 2011
- 18-Fluorine Fluorodeoxyglucose Positron Emission Tomography with Computerized Tomography Versus Computerized Tomography Alone for the Management of Solitary Lung Nodules with Diameters Inferior to 1.5 cmThe Thoracic and Cardiovascular Surgeon, 2010
- Quality assessment of diagnostic before-after studies: development of methodology in the context of a systematic reviewBMC Medical Research Methodology, 2009
- Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodulesLung Cancer, 2008
- Valor do FDG[18F]-PET/TC como preditor de câncer em nódulo pulmonar solitárioJornal Brasileiro de Pneumologia, 2008
- Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomographyNuclear Medicine Communications, 2008
- The Solitary Pulmonary NoduleThe New England Journal of Medicine, 2003